Kenei Furukawa

Dr. Kenei Furukawa


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2022 in Annals of Gastroenterological Surgery
Verified
Journal Article
Open access
MTMasashi Tsunematsu
Masashi Tsunematsu
KHKoichiro Haruki
Koichiro Haruki
TTTomohiko Taniai
Tomohiko Taniai
YTYoshiaki Tanji
Yoshiaki Tanji
YSYoshihiro Shirai
Yoshihiro Shirai
TIToru Ikegami
Toru Ikegami
Aim: The C‐reactive protein (CRP)‐albumin‐lymphocyte (CALLY) index is a novel inflammation‐based biomarker, which has been associated with long‐term outcomes in patients with hepatocellular carcinoma. We aimed to investigate whether the CALLY index can predict the prognosis for distal cholangiocarcinoma after pancreaticoduodenectomy.Methods: The study comprised 143 patients who had undergone primary pancreaticoduodenectomy for distal cholangiocarcinoma between 2002 to 2019. The CALLY index was defined as (albumin × lymphocyte)/ (CRP × 104). We investigated the association of CALLY index with disease‐free survival and overall survival by univariate and multivariate analyses.Results: Eighty‐seven (61%) patients had a preoperative CALLY index <3.5. In multivariate analysis, obstructive jaundice drainage (P < .01), poorly differentiated tumor (P < .01), and CALLY index<3.5 (P = .02) were independent predictors of disease‐free survival, while obstructive jaundice drainage (P < .01), poorly differentiated tumor (P < .01), and CALLY index <3.5 (P = .02) were independent predictors of overall survival.Conclusion: The CALLY index may be an independent and significant indicator of poor long‐term outcomes in patients with distal cholangiocarcinoma after pancreaticoduodenectomy, suggesting the importance of comprehensive assessment for inflammatory status.

18 January 2021 in Annals of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
KFKenei Furukawa
Kenei Furukawa
KHKoichiro Haruki
Koichiro Haruki
TTTomohiko Taniai
Tomohiko Taniai
RHRyoga Hamura
Ryoga Hamura
YSYoshihiro Shirai
Yoshihiro Shirai
TIToru Ikegami
Toru Ikegami
Aim: We investigated the prognostic impact of osteosarcopenia, which is the combination of osteopenia and sarcopenia, in patients with colorectal liver metastases (CRLM) after hepatic resection.Methods: One hundred and eighteen patients were analyzed retrospectively. Osteopenia was evaluated with computed tomographic measurement of pixel density in the midvertebral core of the 11th thoracic vertebra. Sarcopenia was evaluated with psoas muscle areas at the third lumbar vertebra. Osteosarcopenia was defined as the concomitant occurrence of osteopenia and sarcopenia.Results: Osteosarcopenia was identified in 38 (32%) of the patients. In univariate analysis, the overall survival was significantly worse in patients with lymph node metastases (P = .01), extrahepatic lesion (P = .01), sarcopenia (P = .02), osteosarcopenia (P < .01), Glasgow Prognostic Score (GPS) 1 or 2 (P = .05), and curability R 1 or 2 (P = .04). In multivariate analysis, lymph node metastases (P < .01), osteosarcopenia (P < .01), and GPS 1 or 2 (P = .03) were independent and significant predictors of the overall survival. In patients with osteosarcopenia, there were more women than men and body mass index was lower compared to patients without osteosarcopenia.Conclusion: Osteosarcopenia was the strong predictor for outcomes in patients who underwent liver resection for CRLM.

1 October 2017 in The American Journal of Surgery
Verified
Journal Article
Closed access
KHKoichiro Haruki
Koichiro Haruki
HSHiroaki Shiba
Hiroaki Shiba
THTakashi Horiuchi
Takashi Horiuchi
TSTaro Sakamoto
Taro Sakamoto
TGTakeshi Gocho
Takeshi Gocho
KYKatsuhiko Yanaga
Katsuhiko Yanaga

3 July 2017 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
YFYasuro Futagawa
Yasuro Futagawa
MKMasaru Kanehira
Masaru Kanehira
KFKenei Furukawa
Kenei Furukawa
HKHiroaki Kitamura
Hiroaki Kitamura
SYSeiya Yoshida
Seiya Yoshida
KYKatsuhiko Yanaga
Katsuhiko Yanaga

19 October 2022 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
MYMitsuru Yanagaki
Mitsuru Yanagaki
KHKoichiro Haruki
Koichiro Haruki
TTTomohiko Taniai
Tomohiko Taniai
YIYosuke Igarashi
Yosuke Igarashi
JYJungo Yasuda
Jungo Yasuda
TIToru Ikegami
Toru Ikegami

7 July 2021 in International Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
KAKyohei Abe
Kyohei Abe
KFKenei Furukawa
Kenei Furukawa
TOTomoyoshi Okamoto
Tomoyoshi Okamoto
MMMichinori Matsumoto
Michinori Matsumoto
YFYasuro Futagawa
Yasuro Futagawa
TIToru Ikegami
Toru Ikegami